Cargando…

PDE5 Exists in Human Neurons and is a Viable Therapeutic Target for Neurologic Disease

Phosphodiesterase 5 (PDE5) is a critical component of the cGMP-PKG axis of cellular signaling in neurons, and inhibition of PDE5 has been shown to be therapeutic in a wide range of neurologic conditions in animal models. However, enthusiasm for PDE5 inhibitors in humans is limited by data suggesting...

Descripción completa

Detalles Bibliográficos
Autores principales:	Teich, Andrew F., Sakurai, Mikako, Patel, Mitesh, Holman, Cameron, Saeed, Faisal, Fiorito, Jole, Arancio, Ottavio
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	IOS Press 2016
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4927884/ https://www.ncbi.nlm.nih.gov/pubmed/26967220 http://dx.doi.org/10.3233/JAD-151104

Ejemplares similares

A Reliable Way to Detect Endogenous Murine β-Amyloid
por: Teich, Andrew F., et al.
Publicado: (2013)

PDE5 inhibitor drugs for use in dementia
por: Hainsworth, Atticus H., et al.
Publicado: (2023)

Corrigendum: Regulation of synaptic plasticity and cognition by SUMO in normal physiology and Alzheimer’s disease
por: Lee, Linda, et al.
Publicado: (2015)

Regulation of synaptic plasticity and cognition by SUMO in normal physiology and Alzheimer's disease
por: Lee, Linda, et al.
Publicado: (2014)

Dynamin 1 Is Required for Memory Formation
por: Fà, Mauro, et al.
Publicado: (2014)

Synaptic and memory dysfunction induced by tau oligomers is rescued by up-regulation of the nitric oxide cascade
por: Acquarone, Erica, et al.
Publicado: (2019)

Notoginsenoside R1 increases neuronal excitability and ameliorates synaptic and memory dysfunction following amyloid elevation
por: Yan, Shijun, et al.
Publicado: (2014)

Memory-enhancing effects of GEBR-32a, a new PDE4D inhibitor holding promise for the treatment of Alzheimer’s disease
por: Ricciarelli, Roberta, et al.
Publicado: (2017)

Glut4 expression defines an insulin-sensitive hypothalamic neuronal population
por: Ren, Hongxia, et al.
Publicado: (2014)

Activation of PDE10 and PDE11
por: Jäger, Ronald, et al.
Publicado: (2011)

SUMO1 Affects Synaptic Function, Spine Density and Memory
por: Matsuzaki, Shinsuke, et al.
Publicado: (2015)

Alzheimer's Therapeutics Targeting Amyloid Beta 1–42 Oligomers I: Abeta 42 Oligomer Binding to Specific Neuronal Receptors Is Displaced by Drug Candidates That Improve Cognitive Deficits
por: Izzo, Nicholas J., et al.
Publicado: (2014)

Baicalein Ameliorates Aβ-Induced Memory Deficits and Neuronal Atrophy via Inhibition of PDE2 and PDE4
por: Shi, Jing, et al.
Publicado: (2021)

Effects of selenium-containing compounds on Cu(2+)/Zn(2+)-induced neuronal cell death and potential application as therapeutic agents for neurological diseases
por: Tanaka, Ken-ichiro, et al.
Publicado: (2021)

Caspase-9 mediates synaptic plasticity and memory deficits of Danish dementia knock-in mice: caspase-9 inhibition provides therapeutic protection
por: Tamayev, Robert, et al.
Publicado: (2012)

Computational Study on Selective PDE9 Inhibitors on PDE9-Mg/Mg, PDE9-Zn/Mg, and PDE9-Zn/Zn Systems
por: Sivakumar, Dakshinamurthy, et al.
Publicado: (2021)

Differential Expression and Function of PDE8 and PDE4 in Effector T cells: Implications for PDE8 as a Drug Target in Inflammation
por: Vang, Amanda G., et al.
Publicado: (2016)

The Therapeutic Profile of Rolipram, PDE Target and Mechanism of Action as a Neuroprotectant following Spinal Cord Injury
por: Schaal, Sandra Marie, et al.
Publicado: (2012)

Role of phosphodiesterase 5 in synaptic plasticity and memory
por: Puzzo, Daniela, et al.
Publicado: (2008)

Geometric methods in PDE’s
por: Citti, Giovanna, et al.
Publicado: (2015)

Optimization with PDE constraints
por: Pinnau, Rene, et al.
Publicado: (2008)

Targeting Human Central Nervous System Protein Kinases: An Isoform Selective p38αMAPK Inhibitor That Attenuates Disease Progression in Alzheimer’s Disease Mouse Models
por: Roy, Saktimayee M., et al.
Publicado: (2015)

A Selective and Brain Penetrant p38αMAPK Inhibitor Candidate for Neurologic and Neuropsychiatric Disorders That Attenuates Neuroinflammation and Cognitive Dysfunction
por: Roy, Saktimayee M., et al.
Publicado: (2019)

Translational inhibition of APP by Posiphen: Efficacy, pharmacodynamics, and pharmacokinetics in the APP/PS1 mouse
por: Teich, Andrew F., et al.
Publicado: (2018)

PDE3 is the major cGMP-PDE in adult mouse ventricular cardiomyocytes
por: Götz, Konrad R, et al.
Publicado: (2013)

Investigation of PDE5/PDE6 and PDE5/PDE11 selective potent tadalafil-like PDE5 inhibitors using combination of molecular modeling approaches, molecular fingerprint-based virtual screening protocols and structure-based pharmacophore development
por: Kayık, Gülru, et al.
Publicado: (2017)

Correction to “A Selective and Brain Penetrant p38αMAPK Inhibitor Candidate for Neurologic and Neuropsychiatric Disorders That Attenuates Neuroinflammation and Cognitive Dysfunction”
por: Roy, Saktimayee M., et al.
Publicado: (2020)

β- but not γ-secretase proteolysis of APP causes synaptic and memory deficits in a mouse model of dementia
por: Tamayev, Robert, et al.
Publicado: (2012)

Modeling material transport regulation and traffic jam in neurons using PDE-constrained optimization
por: Li, Angran, et al.
Publicado: (2022)

A multifunctional therapeutic approach to disease modification in multiple familial mouse models and a novel sporadic model of Alzheimer’s disease
por: Luo, Jia, et al.
Publicado: (2016)

PDE4 inhibitors as potential therapeutic agents in the treatment of COPD-focus on roflumilast
por: Boswell-Smith, Victoria, et al.
Publicado: (2007)

PDE4 Inhibition and Inflammatory Bowel Disease: A Novel Therapeutic Avenue
por: Spadaccini, Marco, et al.
Publicado: (2017)

Established and emerging therapeutic uses of PDE type 5 inhibitors in cardiovascular disease
por: Tzoumas, Nikolaos, et al.
Publicado: (2020)

Erratum to: A multifunctional therapeutic approach to disease modification in multiple familial mouse models and a novel sporadic model of Alzheimer’s disease
por: Luo, Jia, et al.
Publicado: (2016)

Role of Phosphodiesterase 7 (PDE7) in T Cell Activity. Effects of Selective PDE7 Inhibitors and Dual PDE4/7 Inhibitors on T Cell Functions
por: Szczypka, Marianna
Publicado: (2020)

Frontiers in PDE-constrained optimization
por: Antil, Harbir, et al.
Publicado: (2018)

Numerical PDE-constrained optimization
por: De los Reyes, Juan Carlos
Publicado: (2015)

Trends in PDE constrained optimization
por: Leugering, Günter, et al.
Publicado: (2014)

Pseudodifferential operators and nonlinear PDE
por: Taylor, Michael E
Publicado: (1991)

Control and optimization with PDE constraints
por: Bredies, Kristian, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_90uumj7skfgq2b1dijm9csvmo9